Form 8-K - Current report:
SEC Accession No. 0001213900-24-089430
Filing Date
2024-10-22
Accepted
2024-10-22 08:00:17
Documents
15
Period of Report
2024-10-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0217906-8k_nukkleus.htm   iXBRL 8-K 38048
2 PRESS RELEASE DATED OCTOBER 22, 2024 ea0217906ex99-1_nukkleus.htm EX-99.1 14746
  Complete submission text file 0001213900-24-089430.txt   275577

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nukk-20241022.xsd EX-101.SCH 3820
4 XBRL DEFINITION FILE nukk-20241022_def.xml EX-101.DEF 26706
5 XBRL LABEL FILE nukk-20241022_lab.xml EX-101.LAB 36887
6 XBRL PRESENTATION FILE nukk-20241022_pre.xml EX-101.PRE 25330
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0217906-8k_nukkleus_htm.xml XML 5869
Mailing Address 525 WASHINGTON BLVD JERSEY CITY NJ 07310
Business Address 525 WASHINGTON BLVD JERSEY CITY NJ 07310 212-791-4663
Nukkleus Inc. (Filer) CIK: 0001787518 (see all company filings)

EIN.: 383912845 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-39341 | Film No.: 241384709
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)